covid-19 vaccine strain

Moderna COVID-19 vaccine remains 93% effective for up to 6 months, company says

Reading now: 969
www.fox29.com

CAMBRIDGE, Mass. - Moderna’s COVID-19 vaccine remained 93% effective against symptomatic illness six months after the second dose, but amid the ongoing spread of the highly contagious delta variant, the company said it believes a booster dose will be necessary prior to the winter season.

The company announced the findings Thursday ahead of an earnings call, which also said its vaccine booster candidates produced a "robust" immune response against the delta variant.Moderna said it believes the highly contagious strain of the virus, along with more people indoors as it gets colder, will "lead to an increase of breakthrough infections in vaccinated individuals." "While we see durable Phase 3 efficacy through 6 months, we expect neutralizing.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA